Kura Oncology, Inc.
KURA
$10.86
$0.777.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 14.28% | 5.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.28% | 5.36% | |||
| Cost of Revenue | -5.18% | 1.64% | |||
| Gross Profit | 12.70% | -0.28% | |||
| SG&A Expenses | 0.62% | -19.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.29% | -6.30% | |||
| Operating Income | 7.37% | 8.64% | |||
| Income Before Tax | 6.82% | 9.39% | |||
| Income Tax Expenses | -37.50% | -88.73% | |||
| Earnings from Continuing Operations | 6.83% | 9.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.83% | 9.46% | |||
| EBIT | 7.37% | 8.64% | |||
| EBITDA | 7.42% | 8.62% | |||
| EPS Basic | 7.08% | 10.03% | |||
| Normalized Basic EPS | 7.08% | 18.51% | |||
| EPS Diluted | 7.08% | 10.03% | |||
| Normalized Diluted EPS | 7.08% | 18.51% | |||
| Average Basic Shares Outstanding | 0.28% | 0.64% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||